Dashboard MRSA
Repurposing candidates for MRSA
Methicillin-resistant Staphylococcus aureus
Approved medicines with AI-predicted activity ≥40% against MRSA, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 860
- Existing antimicrobials set aside
- 117
- Needing review
- 72
- Repurposing candidates
- 671
Repurposing candidates for MRSA
AI prediction · nothing measuredAll 671 repurposing candidates for MRSA.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Leucovorin CalciumExisting use: Osteosarcoma52.2% AI-predicted activityagainst MRSA50+ registered studies
- LevoleucovorinExisting use: Anemia, Colorectal adenocarcinoma, Colorectal cancer and 3 more52.2% AI-predicted activityagainst MRSA50+ registered studies
- Fludrocortisone AcetateExisting use: Adrenogenital syndrome, Chronic primary adrenal insufficiency, Primary adrenal insufficiency52.1% AI-predicted activityagainst MRSA50+ registered studies
- Tofacitinib CitrateExisting use: Psoriatic arthritis, Rheumatoid arthritis52.1% AI-predicted activityagainst MRSA50+ registered studies
- VoriconazoleExisting use: Aspergillosis, Bacterial Infections and Mycoses, Candidemia and 4 more52.1% AI-predicted activityagainst MRSA50+ registered studies
- Clobetasol PropionateExisting use: Psoriasis, Psoriasis vulgaris, Skin disease52.1% AI-predicted activityagainst MRSA50+ registered studies
- NatamycinExisting use: Eye infection, Infection52.0% AI-predicted activityagainst MRSA15 registered studies
- Doxacurium ChlorideExisting use: Other quaternary ammonium compounds52.0% AI-predicted activityagainst MRSANo documented evidence found
- Clorazepate DipotassiumExisting use: Anxiety disorder, Seizure52.0% AI-predicted activityagainst MRSA4 registered studies
- Daunorubicin CitrateExisting use: Acute myeloid leukemia, Lymphoid leukemia, Neoplasm52.0% AI-predicted activityagainst MRSALab records exist50+ registered studies
- FelodipineExisting use: Cardiovascular disease, Diabetes mellitus, Hypertension52.0% AI-predicted activityagainst MRSA28 registered studies
- FinerenoneExisting use: Cardiovascular disease, Chronic kidney disease, Type 2 diabetes mellitus52.0% AI-predicted activityagainst MRSA50+ registered studies
- Flavoxate HydrochlorideExisting use: Dysuria, Prostatitis, Urethritis and 1 more52.0% AI-predicted activityagainst MRSA2 registered studies
- Mometasone FuroateExisting use: Airway obstruction, Allergic rhinitis, Asthma and 5 more51.9% AI-predicted activityagainst MRSA50+ registered studies
- Bazedoxifene AcetateExisting use: Postmenopausal osteoporosis51.9% AI-predicted activityagainst MRSA50+ registered studies
- TucatinibExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 6 more51.9% AI-predicted activityagainst MRSA50+ registered studies
- Hydrocortisone Sodium SuccinateExisting use: Adrenal gland disease, Adrenocortical insufficiency, Allergic conjunctivitis and 32 more51.8% AI-predicted activityagainst MRSA50+ registered studies
- TirbanibulinExisting use: Actinic keratosis51.8% AI-predicted activityagainst MRSA20 registered studies
- BrexpiprazoleExisting use: Major depressive disorder, Psychosis, Schizoaffective disorder and 1 more51.8% AI-predicted activityagainst MRSA50+ registered studies
- EfavirenzExisting use: HIV infection, HIV-1 infection, Immunodeficiency disease and 2 more51.8% AI-predicted activityagainst MRSA50+ registered studies
- HaloperidolExisting use: Conduct disorder, Mental or behavioural disorder, Psychosis and 4 more51.8% AI-predicted activityagainst MRSA50+ registered studies
- VamoroloneExisting use: Becker muscular dystrophy, Duchenne muscular dystrophy51.7% AI-predicted activityagainst MRSA12 registered studies
- Delavirdine MesylateExisting use: Viral disease51.7% AI-predicted activityagainst MRSA27 registered studies
- DesoximetasoneExisting use: Psoriasis, Psoriasis vulgaris, Skin disease51.7% AI-predicted activityagainst MRSA10 registered studies